|
|
||||||||
Journal of Leukocyte Biology, Vol 61, Issue 1 50-57, Copyright © 1997 by Society for Leukocyte Biology
JOURNAL ARTICLE |
S Yui, M Mikami, K Tsurumaki and M Yamazaki
Faculty of Pharmaceutical Sciences, Teikyo University, Kanagawa, Japan.
We have shown previously that a calcium-binding protein complex, calprotectin, derived from polymorphonuclear leukocytes exerts a cytostatic and cytolytic effect against a very broad range of tumor cell lines. We also described that calprotectin is an apoptosis-inducing factor for certain tumor cells and that zinc ion attenuates the calprotectin activities. The titers of the factor in body fluids are known to increase greatly in various types of inflammation. In this study, to learn the role of calprotectin in inflammation, the growth-inhibitory and the apoptosis-inducing activities of the factor against normal fibroblasts were examined because fibroblasts are a cell type constituting a local inflammatory site. Rat calprotectin inhibited the growth of murine embryonic as well as human dermal fibroblasts. Although calprotectin induced apoptotic morphology in both fibroblasts, the reaction was slower and less efficient than cases using tumor cells as targets. The activities were significantly abrogated by 10-50 microM Zn2+, Cu2+, Mn2+, or Fe2+, respectively, whereas the trivalent cations Al3+ and Fe3+ had no effect. The dose-response curves of the calprotectin effects were shifted to about 10-fold lower concentration ranges in the divalent metal ion-depleted medium. These results suggest that calprotectin extracellularly affects the inflammatory processes by modulating the growth and survival states of normal fibroblasts, and that the effects are physiologically controlled by several metal ions.
This article has been cited by other articles:
![]() |
S. Ghavami, I. Rashedi, B. M. Dattilo, M. Eshraghi, W. J. Chazin, M. Hashemi, S. Wesselborg, C. Kerkhoff, and M. Los S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway J. Leukoc. Biol., June 1, 2008; 83(6): 1484 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Viemann, K. Barczyk, T. Vogl, U. Fischer, C. Sunderkotter, K. Schulze-Osthoff, and J. Roth MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program Blood, March 15, 2007; 109(6): 2453 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eikmans, M. C. Roos-van Groningen, Y. W.J. Sijpkens, J. Ehrchen, J. Roth, H. J. Baelde, I. M. Bajema, J. W. de Fijter, E. de Heer, and J. A. Bruijn Expression of Surfactant Protein-C, S100A8, S100A9, and B Cell Markers in Renal Allografts: Investigation of the Prognostic Value J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3771 - 3786. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tugizov, J. Berline, R. Herrera, M. E. Penaranda, M. Nakagawa, and J. Palefsky Inhibition of Human Papillomavirus Type 16 E7 Phosphorylation by the S100 MRP-8/14 Protein Complex J. Virol., January 15, 2005; 79(2): 1099 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghavami, C. Kerkhoff, M. Los, M. Hashemi, C. Sorg, and F. Karami-Tehrani Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions J. Leukoc. Biol., July 1, 2004; 76(1): 169 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Seeliger, T. Vogl, I. H. Engels, J. M. Schroder, C. Sorg, C. Sunderkotter, and J. Roth Expression of Calcium-Binding Proteins MRP8 and MRP14 in Inflammatory Muscle Diseases Am. J. Pathol., September 1, 2003; 163(3): 947 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ryckman, K. Vandal, P. Rouleau, M. Talbot, and P. A. Tessier Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion J. Immunol., March 15, 2003; 170(6): 3233 - 3242. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Isaksen and M K Fagerhol Calprotectin inhibits matrix metalloproteinases by sequestration of zinc Mol. Pathol., October 1, 2001; 54(5): 289 - 292. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |